The novel schizophrenia drug showing renewed potential for better outcomes The green light for xanomeline-trospium chloride (Cobenfy; Bristol Myers Squibb) in September 2024 breaks a 70-year drought in novel medicines for schizophrenia. However, its approval by regulators…

In this news feature, #MicheleSolis looks into xanomeline-trospium chloride, the first new medicine treat schizophrenia in decades, and the debate over its benefits compared with current antipsychotic medicines
#ukpharmacy #schizophrenia

Understanding the role of sex hormones in asthma In childhood, asthma is more common in boys than girls. “Mechanistically, we don’t have a clear understanding as to why,” says Dawn Newcomb, an associate professor in allergy, pulmonary and critical…

Asthma is more common and can be more serious in women. Here, science writer #MicheleSolis takes a closer look at the role of sex hormones and how they can improve outcomes in this chronic condition

#asthma #hormonetreatment #womenshealth

Understanding the role of sex hormones in asthma In childhood, asthma is more common in boys than girls. “Mechanistically, we don’t have a clear understanding as to why,” says Dawn Newcomb, an associate professor in allergy, pulmonary and critical…

In this week's feature, #MicheleSolis looks at the role of hormones in asthma and how their use could improve outcomes and eventually lead to the development of new treatment options

#asthmacare #sexhormones

Understanding the role of sex hormones in asthma In childhood, asthma is more common in boys than girls. “Mechanistically, we don’t have a clear understanding as to why,” says Dawn Newcomb, an associate professor in allergy, pulmonary and critical…

In this week's feature, #MicheleSolis highlights how understanding the role of hormones in asthma could improve outcomes and eventually lead to the development of new treatment options
#ukpharmacy #asthma #sexhormones

The novel schizophrenia drug showing renewed potential for better outcomes The green light for xanomeline-trospium chloride (Cobenfy; Bristol Myers Squibb) in September 2024 breaks a 70-year drought in novel medicines for schizophrenia. However, its approval by regulators…

In our latest news feature, #MicheleSolis looks into xanomeline-trospium chloride, the first new medicine treat schizophrenia in decades, and the debate over its benefits compared with current antipsychotic medicines
#ukpharmacy #schizophrenia

https://pharmaceutical-journal.com/article/feature/t…